Skip to content

Effect of resin-based Ayurvedic formulations on physical and mental health of healthy population

An open label, randomized, parallel, two arm [Resins] prospective clinical study of Herbo-mineral Ayurvedic formulation to evaluate the efficacy focusing on their impact on physical and mental health in healthy volunteers - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096625
Enrollment
36
Registered
2025-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male participants aged between 18-60 years having BMI less than 35 kg/m2. 2. Resting blood pressure averaging less than 140 by 90 mm/Hg. 3. Not on any medication for cardiovascular and metabolic disorders. 4. Willing to provide consent and come for follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Participants with any acute illness require immediate medical care. 2. Participants with any chronic medical condition. 3. Any other condition which proves participant unfit for the study participation. 4. Any known cardiovascular or metabolic disease. 5. Participants who are taking any other related supplementation. 6. Serious illness or any other condition that, in the opinion of the investigator, may compromise the safety or compliance of the participant or preclude the successful completion of the study.

Design outcomes

Primary

MeasureTime frame
1.Improvement in strength, power and energy [Balya] 2.Improvement in bone and muscle strength [Balya] (Bone profile basic non fasting examination – ALP, Calcium, serum phosphorus, Vitamin D, Zinc and Parathyroid). 3.Improvement in recovery from weakness [Rasayana] 4.Improvement in performance 5.Improvement in mental health [Medya] (stress, memory and cognition). Timepoint: week 1 and week 12

Secondary

MeasureTime frame
1. Change in serum testosterone levels 2. Safety and tolerability Timepoint: week 1 - visit 1 week 12 - visit 2

Countries

India

Contacts

Public ContactDr Baidyanath Mishra

Dabur India Limited

baidyanath.mishra@dabur.com911203378606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026